Intratech Medical

medical devices

About

Intratech is developing the Booster™ spiral balloon for the semi-occlusion of the coronary sinus, to improve the efficacy of coronary intervention for AMI patients. Around 16 million people worldwide have a heart attack every year. Up to 30% of patients with acute myocardial infarction (AMI) will develop heart failure which has a huge impact on overall health and patient quality of life. After the revascularization of the clogged artery, the Booster™ balloon is placed in the coronary sinus vein, and due to its unique spiral design, it increases vascular pressure. This elevated pressure enhances blood perfusion into the affected myocardium, improving the patient's cardiac function. Intratech has promising pre-clinical results and has launched its First-In-Human clinical trial in 2021. The company has secured a major investment from a key strategic corporation in the interventional cardiology field and has a comprehensive patent family with patents granted globally.

Technologies

Outlook Google Cloud Hosting

Keywords

cardiology & medical devices medical equipment manufacturing revascularization support stroke treatment device medical devices medical device development heart attack therapy medical device innovation cardiology innovation cardiovascular device medical equipment and supplies manufacturing patent portfolio microvascular washout healthcare cost reduction vascular growth factor release b2b vascular growth factors infarct size reduction blood perfusion microvascular perfusion investor-backed medical device spiral balloon design intracoronary pressure healthcare equipment & supplies cardiac care cardiology vascular pressure modulation spiral balloon patented medical technology blood flow enhancement

Location

Shefayim, Center District, Israel

Related Companies

Companies in the same industry